Sara A. Hurvitz, MD, FACP / Miguel Martín, MD, PhD - Integrating Advances in HR+ HER2- Early Breast Cancer: A Focus on Targeted Adjuvant Regimens

episode

CME in Minutes: Education in Oncology & Hematology not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

9/24/26: Nvidia CEO Warns On AI, Professor Pape Dire Election Warning, Bay Of Piglets Survivors Speak Out 1h 16m · 24 Sep 2026 · Breaking Points with Krystal and Saagar

9/24/26: Trump Backs Diesel Export Ban, Latinos Flee GOP, Iran Lashes Out At Israel 1h 11m · 24 Sep 2026 · Breaking Points with Krystal and Saagar

2026-09-24- KSR - Hour 1 1h 4m · 24 Sep 2026 · KSR

Football vs jetlag | Who is the Mayo of the NFL? | Super Bowl favourites | Hockey's coaching scandal | US Sports Roundtable 1h 11m · 24 Sep 2026 · Indo Sport

First Date Follow Up: A Revenge Date With a CRAZY Twist! 17 min · 24 Sep 2026 · First Date Follow Up - The Jubal Show

Jason Sudeikis: JUCO Hoops, SNL & Why Apple Bet on Ted Lasso 1h 24m · 24 Sep 2026 · All The Smoke

Report any issue

Source

Recorded15 Jun 2023

Publisherc.answersincme.com ↗

Handlerec:766079

Show notes

Please visit answersincme.com/MHQ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in oncology discuss how to optimize the use of oral targeted adjuvant therapy in patients with high-risk, HR+ HER2- early breast cancer. Upon completion of this activity, participants should be better able to: Identify which patients with HR-positive HER2-negative (HR+ HER2-) early breast cancer are at high risk for recurrence; Review the clinical significance of the latest data for targeted adjuvant treatment of HR+ HER2- high-risk early breast cancer; Outline proactive, patient-centered strategies to optimize the care of patients with HR+ HER2- high-risk early breast cancer.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in